Simon Graindorge

Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom.

ORA Capital Partners Ltd. is a holding and management company whose principal activity is the development and growth of trading companies within its business portfolio. It is currently focused on technology, resources and financial services opportunities. The company operates through two segments: Business Portfolio Return & Advisory Fees and Financial Trading. The Business Portfolio Return & Advisory Fees segment represents gains and losses on the disposal and revaluation of portfolio investments held. The Financial Trading segment uses surplus cash for specific opportunities. It also engages in trading instruments and has smaller interests in a number of other companies. ORA Capital Partners was founded by Richard Ian Griffiths on November 7, 2005 and is headquartered in St. Peter Port, Guernsey.

Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia.

Lake Technology Ltd. develops and markets digital signal processing systems and algorithms used in audio applications including live concert sound, consumer entertainment products, personal computers, in-flight entertainment, acoustic research, and virtual reality installations. The company was founded by Brian Conolly and David McGrath in 1991 and is headquartered in Sydney, Australia.

Maine & Co. provides site selection services. Its services include real estate site searches, data collection & analysis, incentives identification & valuation, site visit coordination, and financing coordination services. The company was founded in 1995 and is headquartered in Portland, ME.

Metro Atlanta Chamber of Commerce is a non-profit organization, which engages in improving the quality of place and advancing economic growth. It focuses on growing the region's innovation economy by promoting and strengthening connections. The company was founded in 1860 and is headquartered in Atlanta, GA.

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

OXECO Ltd. develops technology which enables the modification of the surface properties. It offers adhesion promotion, fibre sizing and surface wetting solutions. The firm serves automotive, aerospace, marine, industrial, defense and energy industries. The company was founded in 2006 and is headquartered in Begbroke, the United Kingdom.

The Oxford Trust provides information on science and technology. The organization was founded by Martin and Lady Wood in 1959 and is headquartered in Oxford, the United Kingdom.

Signostics Ltd. provides ultrasound devices. It offers Uscan and Signosrt Handheld Ultrasound scanner. The company was founded by Neil Bartlett and Stewart Bartlett in 2005 and is headquartered in Adelaide, Australia.

ORA (Guernsey) Ltd. operates as a holding company. The company is headquartered in the United Kingdom.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia.

Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia.

MiReven Pty Ltd. operates as an Australian biopharmaceutical company. The private company is based in Nedlands, Australia.

MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia.

Ferronova Pty Ltd. operates as a bionanoengineering company. Its research activities focuses on interface of materials science, nanoscience, bioengineering, and medicine. It develops an enhanced cancer detecting magnetic probe system. The company was founded on May 27, 2016 and is headquartered in Adelaide, Australia.

Serendipity Capital Ltd. provides financial services. The private company is based in St. Peter Port, UK.

Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia.

Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.

Respirion Pharmaceuticals Pty Ltd. operates as a biotechnology firm. It focuses on development new treatments for respiratory diseases. The company was founded by Barry Clements in 2018 and is headquartered in Iluka, Australia.